|
1
|
Próchnicki T, Mangan MS and Latz E: Recent
insights into the molecular mechanisms of the NLRP3 inflammasome
activation. F1000Res 5: pii: F1000 Faculty Rev. 14692016.
|
|
2
|
Kim Y, Wang W, Okla M, Kang I, Moreau R
and Chung SJ: Suppression of NLRP3 inflammasome by γ-tocotrienol
ameliorates type 2 diabetes. Lipid Res. 57:66–76. 2016. View Article : Google Scholar
|
|
3
|
Shin MS, Kang Y, Lee N, Wahl ER, Kim SH,
Kang KS, Lazova R and Kang I: Self double-stranded (ds)DNA induces
IL-1β production from human monocytes by activating NLRP3
inflammasome in the presence of anti-dsDNA antibodies. J Immuno.
190:1407–1415. 2013. View Article : Google Scholar
|
|
4
|
Tschopp J and Schroder K: NLRP3
inflammasome activation: The convergence of multiple signalling
pathways on ROS production? Nat Rev Immunol. 10:210–215. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Arbore G, West EE, Spolski R, Robertson
AA, Klos A, Rheinheimer C, Dutow P, Woodruff TM, Yu ZX, O'Neill LA,
et al: T helper 1 immunity requires complement-drivenNLRP3
inflammasome activity in CD4+ T cells. Science.
352:aad12102016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bruchard M, Rebé C, Derangère V, Togbé D,
Ryffel B, Boidot R, Humblin E, Hamman A, Chalmin F, Berger H, et
al: The receptor NLRP3 is a transcriptional regulator of TH2
differentiation. Nat Immunol. 16:859–870. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Martin BN, Wang C, Zhang CJ, Kang Z, Gulen
MF, Zepp JA, Zhao J, Bian G, Do JS, Min B, et al: T cell-intrinsic
ASC critically promotes T(H)17-mediated experimental autoimmune
encephalomyelitis. Nat Immunol. 17:583–592. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mortimer L, Moreau F, MacDonald JA and
Chadee K: NLRP3 inflammasome inhibition is disrupted in a group of
auto-inflammatory disease CAPS mutations. Nat Immunol.
17:1176–1186. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
White CS, Lawrence CB, Brough D and
Rivers-Auty J: Inflammasomes as therapeutic targets for Alzheimer's
disease. Brain Pathol. 27:223–234. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kim Y, Wang W, Okla M, Kang I, Moreau R
and Chung S: Suppression of NLRP3 inflammasome by γ-tocotrienol
ameliorates type 2 diabetes. J Lipid Res. 57:66–76. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lu A, Li H, Niu J, Wu S, Xue G, Yao X, Guo
Q, Wan N, Abliz P, Yang G, et al: Hyperactivation of the NLRP3
inflammasome in myeloid cells leads to severe organ damage in
experimental lupus. J Immunol. 198:1119–1129. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fernández-Riejos P, Najib S,
Santos-Alvarez J, Martín-Romero C, Pérez-Pérez A, González-Yanes C
and Sánchez-Margalet V: Role of leptin in the activation of immune
cells. Mediators Inflamm. 2010:5683432010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yu Y, Liu Y, Shi FD, Zou H, Matarese G and
La Cava A: Cutting edge: Leptin-induced RORγt Expression in
CD4+ T cells promotes Th17 responses in systemic lupus
erythematosus. Immunol. 190:3054–3058. 2013. View Article : Google Scholar
|
|
14
|
Liu Y, Yu Y, Matarese G and La Cava A:
Cutting edge: Fasting-induced hypoleptinemia expands functional
regulatory T cells in systemic lupuserythematosus. J Immunol.
188:2070–2073. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang X, Chrysovergis K, Kosak J and Eling
TE: Lower NLRP3 inflammasome activity in NAG-1 transgenic mice is
linked to a resistance to obesity and increased insulin
sensitivity. Obesity (Silver Spring). 22:1256–1263. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Scmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gross O, Thomas CJ, Guarda G and Tschopp
J: The inflammasome: An integrated view. Immunol Rev. 243:136–151.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fu S, Xu L, Li S, Qiu Y, Liu Y, Wu Z, Ye
C, Hou Y and Hu CA: Baicalin suppresses NLRP3 inflammasome and
nuclear factor-kappa B (NF-κB) signaling during Haemophilus
parasuis infection. Vet Res. 47:802016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Braga TT, Forni MF, Correa-Costa M, Ramos
RN, Barbuto JA, Branco P, Castoldi A, Hiyane MI, Davanso MR, Latz
E, et al: Soluble uric acid activates the NLRP3 inflammasome. Sci
Rep. 7:398842017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yin Y, Zhou Z, Liu W, Chang Q, Sun G and
Dai Y: Vascular endothelial cells senescence is associated with
NOD-like receptor family pyrin domain-containing 3 (NL RP3)
inflammasome activation via reactive oxygen species
(ROS)/thioredoxin-interacting protein (TXNIP) pathway. Int J
Biochem Cell Biol. 84:22–34. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Toksoy A, Sennefelder H, Adam C, Hofmann
S, Trautmann A, Goebeler M and Schmidt M: Potent NLRP3 inflammasome
activation by the HIV reverse-transcriptase inhibitor abacavir. J
Biol Chem. 292:2805–2814. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kang MJ, Jo SG, Kim DJ and Park JH: NLRP3
inflammasome mediates interleukin-1β production in immune cells in
response to Acinetobacter baumannii and contributes to pulmonary
inflammation in mice. Immunology. 150:495–505. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gong Z, Zhou J, Zhao S, Tian C, Wang P, Xu
C, Chen Y, Cai W and Wu J: Chenodeoxycholic acid activates NLRP3
inflammasome and contributes to cholestatic liver fibrosis.
Oncotarget. 7:83951–83963. 2016.PubMed/NCBI
|
|
24
|
Groß CJ, Mishra R, Schneider KS, Médard G,
Wettmarshausen J, Dittlein DC, Shi H, Gorka O, Koenig PA, Fromm S,
et al: K+ Efflux-Independent NLRP3 inflammasome
activation by small molecules targeting mitochondria. Immunity.
45:761–773. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lee JH, Cho DH and Park HJ: IL-18 and
Cutaneous Inflammatory Diseases. Int J Mol Sci. 16:29357–29369.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sims JE and Smith DE: The IL-1 family:
Regulators of immunity. Nat Rev Immunol. 10:89–102. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Puren AJ, Fantuzzi G and Dinarello CA:
Gene expression, synthesis, and secretion of interleukin 18 and
interleukin 1beta are differentially regulated in human blood
mononuclear cells and mouse spleen cells. Proc Nat Acad Sci USA.
96:pp. 2256–2561. 1999; View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Arend WP, Palmer G and Gabay C: IL-1,
IL-18, and IL-33 families of cytokines. Immunol Rev. 223:20–38.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li K, Wei L, Huang Y, Wu Y, Su M, Pang X,
Wang N, Ji F, Zhong C, Chen T, et al: Leptin promotes breast cancer
cell migration and invasion via IL-18 expression and secretion. Int
J Oncol. 48:2479–2487. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Schmidt RL and Lenz LL: Distinct licensing
of IL-18 and IL-1β secretion in response to NLRP3 inflammasome
activation. PLoS One. 7:e451862012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jitprasertwong P, Jaedicke KM, Nile CJ,
Preshaw PM and Taylor JJ: Leptin enhances the secretion of
interleukin (IL)-18, but not IL-1β, from human monocytes via
activation of caspase-1. Cytokine. 65:222–230. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gabay C, Dreyer M, Pellegrinelli N,
Chicheportiche R and Meier CA: Leptin directly induces the
secretion of interleukin 1 receptor antagonist in human monocytes.
J Clin Endocrinol Metab. 86:783–791. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Dixit VD, Schaffer EM, Pyle RS, Collins
GD, Sakthivel SK, Palaniappan R, Lillard JW Jr and Taub DD: Ghrelin
inhibits leptin-and activation-induced proinflammatory cytokine
expression by human monocytes and T cells. J Clin Invest.
114:57–66. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mattioli B, Straface E, Quaranta MG,
Giordani L and Viora M: Leptin promotes differentiation and
survival of human dendritic cells and licenses them for Th1
priming. J Immunol. 174:6820–6828. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ahmed M, Shaban Z, Yamaji D,
Okamatsu-Ogura Y, Soliman M, Abd Eldaim M, Ishioka K, Makondo K,
Saito M and Kimura K: Induction of proinflammatory cytokines and
caspase-1 by leptin in monocyte/macrophages from holstein cows. J
Vet Med Sci. 69:509–514. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chen CY, Yang CH, Tsai YF, Liaw CC, Chang
WY and Hwang TL: Ugonin U stimulates NLRP3 inflammasome activation
and enhances inflammasome-mediated pathogen clearance. Redox Biol.
11:263–274. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lordén G, Sanjuán-García I, de Pablo N,
Meana C, Alvarez-Miguel I, Pérez-García MT, Pelegrín P, Balsinde J
and Balboa MA: Lipin-2 regulates NLRP3 inflammasome by affecting
P2X7 receptor activation. J Exp Med. 214:511–528. 2016. View Article : Google Scholar : PubMed/NCBI
|
